US EditionMcKinsey to contribute $125 million to Purdue bankruptcy over opioid sales advice
2 Articles
2 Articles
McKinsey to contribute $125 million to Purdue bankruptcy over opioid sales advice
Consulting firm McKinsey & Co has agreed to contribute $125 million to Purdue Pharma's bankruptcy settlement, resolving potential legal claims over advice it provided to Purdue on how to “turbocharge” sales of its addictive painkiller OxyContin, according to a court filing submitted late Wednesday.
McKinsey to contribute $125 million to Purdue bankruptcy over opioid sales advice - Regional Media News
By Dietrich Knauth NEW YORK, April 9 (Reuters) - Consulting firm McKinsey & Co has agreed to contribute $125 million to Purdue Pharma's bankruptcy settlement, resolving potential legal claims over advice it provided to Purdue on how to "turbocharge" sales of its addictive painkiller OxyContin, according to a court filing submitted late Wednesday. Purdue, which received bankruptcy court approval of a $7.4 billion restructuring plan in November, w…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
